Tasimelteon CAS 609799-22-6

Iden­ti­fi­ca­tion Prop­er­ties Safe­ty Data Spec­i­fi­ca­tions andamp ; Oth­er Information Links

Iden­ti­fi­ca­tion

CAS Number

609799-22-6

Name

Tasimelteon

Syn­onyms

609799-22-6 [RN] Het­lioz [Trade name] (1R-trans)-N-[[2-(2,3-Dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide N-{[(1R,2R)-2-(2,3-Dihydro-1-benzofuran-4-yl)cyclopropyl]methyl}propanamid [Ger­man] [ACD/IUPAC Name] N-{[(1R,2R)-2-(2,3-Dihydro-1-benzofuran-4-yl)cyclopropyl]methyl}propanamide [ACD/IUPAC Name] N-{[(1R,2R)-2-(2,3-Dihydro-1-benzofuran-4-yl)cyclopropyl]méthyl}propanamide [French] [ACD/IUPAC Name] Propanamide, N-[[(1R,2R)-2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]- [ACD/​Index Name] Tasimelteon [INN] [USAN] [Wiki] tasimelteón [Span­ish] [INN] tasimeltéon [French] [INN] tasimelteon­um [Latin] [INN]

Mol­e­c­u­lar Structure

Mol­e­c­u­lar Formula

C15H19NO2

Mol­e­c­u­lar Weight

245.32

SMILES

CCC(=O)NC[C@@H]1C[C@H]1C2=C3CCOC3=CC=C2

Std­InChI

InChI=1S/C15H19NO2/c1-2-15(17)16-9-10-8-13(10)11-4-3-5-14-12(11)6-7-18-14/h3-5,10,13H,2,6-9H2,1H3,(H,16,17)/t10-,13+/m0/s1

Std­InChIKey

PTOIAAW­­ZLUQ­­TIO-GXF­FZT­­MASA-N

Prop­er­ties

Appear­ance

White crys­talline pow­der

Spec­i­fi­ca­tions and Oth­er Infor­ma­tion of Our Tasimelteon CAS 609799-22-6

Stan­dard

Enter­prise stan­dard

Iden­ti­fi­ca­tion Methods

HNMR,HPLC

Puri­ty

98% min

Stor­age

Under room tem­per­a­ture away from light

Appli­ca­tion

It is a drug which is under devel­op­ment for the treat­ment of insom­nia and oth­er sleep dis­or­ders. It is a selec­tive ago­nist for the mela­tonin recep­tors MT1 and MT2 in the suprachi­as­mat­ic nucle­us of the brain, sim­i­lar to old­er drugs such as ramelteon.

Gen­er­al View of Documents

Links

This prod­uct is devel­oped by our RD com­pa­ny Cam­ing Phar­ma­ceu­ti­cal Ltd(http://​www​.cam​ing​.com/), and here is the cor­re­spond­ing linkhttp://​cam​ing​.com/​t​a​s​i​m​e​l​t​e​o​n​-​c​a​s​-​6​0​9​7​9​9​-​2​2​-6/

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you short­ly (Please change screen to hor­i­zon­tal for com­plete brows­ing if you are check­ing Wat­son on your mobile phone).